Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 3Other hematologic neoplasm 2Other 2Other neoplasm 1Myeloid 1CNS 1Breast 1

Conditions

Precancerous Conditions 26Neoplasms 8Obesity-Related Malignant Neoplasm 7Myelodysplastic Syndromes 5Leukemia, Myeloid, Acute 5Leukemia 5Uterine Cervical Neoplasms 4Preleukemia 4Neoplasms by Histologic Type 4Hematologic Diseases 4Bone Marrow Diseases 4Primary Myelofibrosis 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Myeloproliferative Disorders 3Lymphoma 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia, Biphenotypic, Acute 3Keratosis, Actinic 3Immunoproliferative Disorders 3Immune System Diseases 3Head and Neck Neoplasms 3Colorectal Neoplasms 3Colonic Neoplasms 3Advanced Malignant Neoplasm 3Uterine Cervical Dysplasia 2Thrombocythemia, Essential 2Stomach Neoplasms 2Skin Diseases 2Neoplasms by Site 2Myelodysplastic-Myeloproliferative Diseases 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Syndrome × Other neoplasm × 1 year × Clear all
NCT07216443 2026-04-15

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Orca Biosystems, Inc.

Phase 2 Recruiting
80 enrolled
MyeloidOther hematologic neoplasmOther neoplasm

Acute Disease, Bone Marrow Diseases, Disease, Graft vs Host Disease, Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Myelodysplastic Syndromes, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Precancerous Conditions, Preleukemia, Syndrome, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Disease Attributes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡